Telenor Q2 Organic Revenue Growth 3.3%

Telenor ASA (OTC: TELNY) reported a second-quarter FY21 revenue decline of 6.3% year-on-year to about $3.01 billion (NOK 27.2 billion). (1$ = 9.05 Norwegian Krone as of July 20).
  • Telenor ASA (OTC:TELNY) reported a second-quarter FY21 revenue decline of 6.3% year-on-year to about $3.01 billion (NOK 27.2 billion). (1$ = 9.05 Norwegian Krone as of July 20).
  • Organic revenue grew 3.3% Y/Y.
  • Subscription and traffic revenues increased by 2% Y/Y on an organic basis.
  • The growth reflects strong performance in the Nordics combined with a growing subscriber base and increased data consumption in the Asian markets.
  • The company’s mobile subscriber base rose by 1.7 million.
  • Organic EBITDA grew 3.6% Y/Y.
  • EBITDA margin remained flat at 45.5%.
  • The net income was about $243 million (NOK 2.2 billion).
  • The company generated $1.08 billion (NOK 9.8 billion) in net cash flow from operating activities.
  • It held $2.2 billion (NOK 19.7 billion) in cash and equivalents.
  • Outlook: It currently sees organic subscription and traffic revenues growth of 0-1%, organic EBITDA growth of 0-2% in FY21.
  • In June, Telenor paid the first tranche of the dividend for 2020 of NOK 6.7 billion or NOK 5.0 per share.
  • On July 8, the Group announced an agreement to sell its operations in Myanmar. 
  • Price action: TELNY shares are trading up by 2.91% at $17.05 on the last check Tuesday.
Total
0
Shares
Related Posts
Read More

Pfizer Provides Update On Ownership Interest In Haleon; Haleon To Become Publicly Listed Standalone Company In July; Pfizer Will Continue To Hold 32% Ownership In Haleon, Will Exit Ownership Interest In A ‘Disciplined Manner’

Pfizer Provides Update on Ownership Interest in Haleon Haleon to Become a Publicly Listed Standalone Company in July Following a Demerger by GSK Post-Demerger, Pfizer Plans to Exit Ownership Interest in Haleon in a

GSK